Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway
Authors
Keywords
SREBP-2 transgenic rats, SREBP-2/SIRT1/FOXO1 signaling pathway, Cholesterol synthesis
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-02-14
DOI
10.1007/s11010-018-3324-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice
- (2018) Mousumi Bose et al. JOURNAL OF NUTRITION
- A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2
- (2017) Yujie Li et al. HEPATOLOGY
- FOXO1 is crucial in glioblastoma cell tumorigenesis and regulates the expression of SIRT1 to suppress senescence in the brain
- (2017) Han Yan et al. Molecular Medicine Reports
- Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass
- (2016) Masaki Funamoto et al. ANNALS OF THORACIC SURGERY
- SIRT1 is a critical regulator of K562 cell growth, survival, and differentiation
- (2016) Mark T. Duncan et al. EXPERIMENTAL CELL RESEARCH
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expressionin Vivoandin Vitrothrough a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter
- (2016) Amar Bahadur Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Risk factors and subtypes of acute ischemic stroke. A study at King Fahd Hospital of the University
- (2016) Azra Zafar et al. Neurosciences
- Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease
- (2015) A. M. Navar-Boggan et al. CIRCULATION
- SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway
- (2015) C. C. S. Chini et al. CLINICAL CANCER RESEARCH
- MicroRNA-214 Suppresses Gluconeogenesis by Targeting Activating Transcriptional Factor 4
- (2015) Kai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigallocatechin gallate potentially attenuates Fluoride induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats
- (2015) S. Miltonprabu et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake
- (2015) Jonathan W. Haskins et al. Science Signaling
- Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion
- (2015) Yuting Wu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake
- (2015) Jonathan W. Haskins et al. Science Signaling
- Redox regulation of FoxO transcription factors
- (2015) Lars-Oliver Klotz et al. Redox Biology
- CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis
- (2014) Kyoung-Jin Oh et al. BMB Reports
- Treatment of Non-Alcoholic Fatty Liver Disease
- (2014) Jessica Dyson et al. DIGESTIVE DISEASES
- EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
- (2014) Eun-Ji Yang et al. PLoS One
- Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy
- (2013) PING ZHOU et al. Molecular Medicine Reports
- FoxO1 Inhibits Sterol Regulatory Element-binding Protein-1c (SREBP-1c) Gene Expression via Transcription Factors Sp1 and SREBP-1c
- (2012) Xiong Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotective effect of (–)-epigallocatechin-3-gallate in rats when administered pre- or post-traumatic brain injury
- (2012) Tatsuki Itoh et al. JOURNAL OF NEURAL TRANSMISSION
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
- (2012) Zheng Sun et al. NATURE MEDICINE
- Hyperlipidemia as a Risk Factor for Cardiovascular Disease
- (2012) Robert H. Nelson PRIMARY CARE
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
- (2011) Brahma N. Singh et al. BIOCHEMICAL PHARMACOLOGY
- FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes
- (2011) Shin Tsunekawa et al. DIABETES
- Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo
- (2010) Phan LCHB Tran et al. BMC CANCER
- EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling
- (2010) Hsiu-Chung Ou et al. JOURNAL OF APPLIED PHYSIOLOGY
- DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
- (2010) Xiumei Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SREBPs: protein interaction and SREBPs
- (2008) Ryuichiro Sato FEBS Journal
- Epigallocatechin Gallate, a Green Tea Phytochemical, Attenuates Alcohol-Induced Hepatic Protein and Lipid Damage
- (2008) S. Kaviarasan et al. TOXICOLOGY MECHANISMS AND METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now